RxDoctor Payments Data

Gina Laughlin, APRN

Nurse Practitioner · Louisville, KYNPI 1922363845

Payments from drug & device makers

$1,856in general payments, 2019–2025

Across 118 payments — averaging $15.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$492
  • Lilly USA, LLC$290
  • Novo Nordisk$288
  • Pfizer$186
  • Exact Sciences$93
  • GSK$61
  • plus $446 from 15 others

What the payments were for

  • Food & beverage$1,856100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,856 in reported general payments places this provider in the 75th percentile of 1,918 nurse practitioner providers in Kentucky.

See all nurse practitioner providers in Kentucky

Medicare billing

Part B allowed, 2024
$83,657
Medicare patients
206
Services billed
1,666

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter75$54,561
OzempicSemaglutide46$48,931
EliquisApixaban21$30,160
LinzessLinaclotide24$30,089
JanuviaSitagliptin Phosphate19$21,957
MounjaroTirzepatide19$19,906
TradjentaLinagliptin11$12,722
Breztri AerosphereBudesonide/Glycopyr/Formoterol17$10,862
MyrbetriqMirabegron16$10,203
Spiriva HandihalerTiotropium Bromide11$5,483
Combivent RespimatIpratropium/Albuterol Sulfate11$5,295
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr12$4,860
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog22$3,943
Albuterol Sulfate HfaAlbuterol Sulfate144$3,392
Atorvastatin Calcium484$3,311

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Anoro Ellipta$61$59,42187 claims
Novo NordiskOzempic$288$48,93146 claims
AbbVieLinzess, Synthroid$492$31,99851 claims
PfizerEliquis$186$30,16021 claims
MerckJanuvia$40$21,95719 claims
Lilly USA, LLCMounjaro$290$19,90619 claims
Astellas Pharma US IncMyrbetriq$55$10,20316 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,918 nurse practitioner providers in Kentucky.

Other nurse practitioner in Louisville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →